Riskpilot← Back to searchSign inGet full accessAdesso Nutraceuticals Oy
OYActiveY-tunnus 2616860-2Kutojantie 68Wholesale of other food · NACE 4638Est. 20141 employees
Revenue 2024
EUR 352K
-23% vs 2023
EBITDA margin
2.7%
+116% vs 2023
Equity ratio
6.5%
Financial strength
Net profit 2024
EUR 6K
+83% vs 2023
| Revenue | EUR 352K | -23% |
| EBITDA | EUR 10K | +116% |
| Net profit | EUR 6K | +83% |
| Total assets | EUR 126K | +0% |
| Equity | EUR 8K | +249% |
| Employees | 1 | — |
Legal name
Adesso Nutraceuticals Oy
Y-tunnus number
2616860-2
Legal form
Osakeyhtiö
NACE code
4638 · Wholesale of other food
Founded
14. huhtikuuta 2014
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Terveystuotteiden ja lääkinnällisten laitteiden maahantuonti, markkinointi ja viestintä sekä kaikki muu laillinen liiketoiminta.
Address
Kutojantie 68
Phone
+3580400195691
Email
asiakaspalvelu@adesso.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 612 | 1 760 | 714 | 460 | 352 |
| Staff expenses | −2 | −22 | −167 | −85 | −65 |
| EBITDA | 164 | 197 | −158 | 4 | 10 |
| Depreciation & amort. | −3 | −24 | — | −0 | −0 |
| EBIT | 162 | 173 | −158 | 4 | 9 |
| Net financials | −3 | −2 | −1 | −1 | −3 |
| Profit before tax | 159 | 171 | −159 | 3 | 6 |
| Tax | −0 | 35 | −0 | −0 | −0 |
| Net profit | 159 | 136 | −159 | 3 | 6 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 269 | 740 | 23 | 126 | 126 |
| Equity | 44 | 172 | −1 | 2 | 8 |
| Long-term debt | 81 | — | — | 0 | 0 |
| Short-term debt | 143 | 568 | 24 | 124 | 124 |
| Total debt | 225 | 568 | 24 | 124 | 124 |
EBITDA margin
2.7%
This company
15.8%
Market median
-83% vs market
20202024
Equity ratio
6.5%
This company
38.2%
Market median
-83% vs market
20202024
Return on equity
71.4%
This company
18.4%
Market median
+288% vs market
20202024
Net profit margin
1.7%
This company
8.1%
Market median
-79% vs market
20202024
Asset turnover
2.79×
This company
1.12×
Market median
+149% vs market
20202024
Debt / equity
14.41×
This company
0.62×
Market median
-2224% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
UI Deputy Member | Deputy Member | 2022 |
MP Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (5) | ||
MA Chief Executive Officer | Chief Executive Officer | 2014 – 2022 |
KP Confidential Clerk | Confidential Clerk | 2021 – 2022 |
SJ Deputy Member | Deputy Member | 2014 – 2021 |
RL | Audit | 2021 – 2023 |
PH Deputy auditor | Deputy auditor | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairperson | 2024 | |
| Former (1) | ||
| Chairperson | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Adesso Nutraceuticals Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulla Ingrid Cederberg | Deputy Member | 0 companies |
| Merja Anneli Heponiemi | Chief Executive Officer | 0 companies |
| Kristiina Päivi Johanna Ylihonko | Confidential Clerk | 0 companies |
| Mika Pentti Kaarlo Cederberg | Chief Executive Officer | 0 companies |
| Seppo Juhani Heponiemi | Deputy Member | 0 companies |
| Robert Leonard Wetterstein | Audit | 0 companies |
| Paul Henrik Vikman | Deputy auditor | 0 companies |
| Jan Oddvar Johansen | Chairperson | 0 companies |
| Nicholas Avierinos | Chairperson | 0 companies |